pipeline

ANG-3777

ANG-3070

ANG-3070, is a highly selective, orally-bioavailable small molecule tyrosine kinase receptor inhibitor developed internally as a potential treatment for fibrotic diseases, particularly in the lung and kidney. ANG-3070 is an investigational product and is not approved by any regulatory authority.

ROCK2 Inhibitor